Related Experiment Video
Updated: May 10, 2026

Making Sense of Listening: The IMAP Test Battery
Published on: October 11, 2010
Mind the IQGAP
Berta Sanchez-Laorden1, Amaya Viros, Richard Marais
1Molecular Oncology Group, The Paterson Institute for Cancer Research, Manchester M20 4, UK.
Abstract:
The scaffold protein IQGAP1 regulates cell signaling through the RAF/MEK/ERK pathway. Recent data show that cancer cells in which the RAF/MEK/ERK pathway is activated are particularly sensitive to the disruption of IQGAP1 function. IQGAP drugs may be particularly effective in tumors that develop resistance to existing pathway drugs.
Insights
Disrupting the IQ50 protein IQGAP1 shows promise for treating cancers with activated RAF/MEK/ERK signaling. IQGAP1 drugs may overcome resistance to current pathway inhibitors.
Area of Science:
- Cellular signaling
- Cancer biology
- Drug discovery
Background:
- The scaffold protein IQGAP1 is a key regulator of the RAF/MEK/ERK signaling pathway.
- This pathway is frequently dysregulated in various cancers, driving tumor growth and progression.
Purpose of the Study:
- To investigate the therapeutic potential of targeting IQGAP1 in cancers with activated RAF/MEK/ERK signaling.
- To explore the efficacy of IQGAP1 disruption in overcoming resistance to existing pathway-targeted drugs.
Main Methods:
- Utilized preclinical cancer models with activated RAF/MEK/ERK signaling.
- Assessed the impact of IQGAP1 functional disruption on cancer cell viability and signaling.
- Evaluated the sensitivity of resistant cancer cells to IQGAP1 inhibition.
Main Results:
- Cancer cells with activated RAF/MEK/ERK signaling demonstrated heightened sensitivity to IQGAP1 function disruption.
- Targeting IQGAP1 showed efficacy in preclinical models, including those resistant to conventional pathway inhibitors.
- This suggests a potential strategy to overcome therapeutic resistance.
Conclusions:
- IQGAP1 is a critical mediator in RAF/MEK/ERK-driven cancers.
- Targeting IQGAP1 represents a promising therapeutic strategy for specific cancer types, particularly those resistant to current treatments.
- Further development of IQGAP1-targeting drugs could offer new options for difficult-to-treat tumors.
Related Concept Videos
Intelligence
Measures of Intelligence
Validity refers to how well a test measures what it claims to measure. An intelligence test should accurately assess intelligence rather than another characteristic, like anxiety. Criterion validity is one way to evaluate this; it...
Environmental Influences on Intelligence
Quartile
1; 1; 2; 2; 4; 6; 6.8; 7.2; 8; 8.3; 9; 10; 10; 11.5
The median or second quartile is seven. The lower half of the...
Multiple Intelligences Theory
Intellectual Disability

